Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-terminal binding protein 2 (CTBP2) is a transcriptional corepressor involved in gene repression through recruitment of chromatin-modifying enzymes. It forms complexes with DNA-binding proteins carrying the PIDLS motif and orchestrates removal or addition of histone marks to regulate gene activity. CTBP2 is expressed in various tissues and is implicated in cellular differentiation, development, and disease processes such as cancer and neurodevelopmental disorders. CTBP2 pseudogene 8 refers to a presumed non-functional genomic element; there is no evidence of protein-coding or therapeutic relevance for CTBP2P8. Researchers should refer to CTBP2 for meaningful biological or disease associated functions. CTBP2P8 (CTBP2 pseudogene 8) is not a validated target, is likely a mislabeling or artifact, and does not correspond to any protein, therapeutic target, or known biomarker. All functionally relevant information pertains to the canonical CTBP2, a transcriptional corepressor and scaffold involved in gene repression, with disease relevance in cancer and neurodevelopmental disorders.
Not applicable—no drugs directly target CTBP2 or its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTBP2 pseudogene 8 (CTBP2P8).